Filing Details
- Accession Number:
- 0001203311-21-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-09 20:13:59
- Reporting Period:
- 2021-04-08
- Accepted Time:
- 2021-04-09 20:13:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-08 | 300 | $15.46 | 715,509 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-08 | 300 | $147.15 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-08 | 4,739 | $15.46 | 719,948 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-08 | 4,739 | $146.41 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-08 | 2,545 | $15.46 | 717,754 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-08 | 2,545 | $145.43 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-08 | 9,167 | $15.46 | 724,376 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-08 | 9,167 | $144.40 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-09 | 300 | $15.46 | 715,509 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-09 | 300 | $143.95 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-09 | 1,009 | $15.46 | 716,218 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-09 | 1,009 | $143.24 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-09 | 5,192 | $15.46 | 720,401 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-09 | 5,192 | $142.22 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-09 | 6,101 | $15.46 | 721,310 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-09 | 6,101 | $141.42 | 715,209 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-04-08 | 300 | $0.00 | 300 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-04-08 | 4,739 | $0.00 | 4,739 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-04-08 | 2,545 | $0.00 | 2,545 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-04-08 | 9,167 | $0.00 | 9,167 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-04-09 | 300 | $0.00 | 300 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-04-09 | 1,009 | $0.00 | 1,009 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-04-09 | 5,192 | $0.00 | 5,192 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-04-09 | 6,101 | $0.00 | 6,101 | $15.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 146,465 | 2021-08-24 | No | 4 | M | Direct | |
| 141,726 | 2021-08-24 | No | 4 | M | Direct | |
| 139,181 | 2021-08-24 | No | 4 | M | Direct | |
| 130,014 | 2021-08-24 | No | 4 | M | Direct | |
| 129,714 | 2021-08-24 | No | 4 | M | Direct | |
| 128,705 | 2021-08-24 | No | 4 | M | Direct | |
| 123,513 | 2021-08-24 | No | 4 | M | Direct | |
| 117,412 | 2021-08-24 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $146.99 to $147.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $145.89 to $146.79. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $144.88 to $145.84. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $143.88 to $144.81 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $142.86 to $143.83. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $141.85 to $142.83. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $140.83 to $141.82 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Shares vested at a rate of 25% on 8/24/12 and monthly thereafter until all the shares were fully vested on 8/24/15.
Billionaire Hedge Funds
